Clinical trial of implantable rechargeable Spinal Cord Stimulator (SCS)
The SCS developed by Rishena Medical has been supported by the national key R & D plan project. It uses innovative technology, and its quality and performance have reached the international advanced level. The clinical trial is now officially started, which marks another breakthrough in China's core technology of high-end medical devices, which is expected to break the prolonged monopoly situation of imported devices, thereby effectively solving the problem of "expensive medical treatment" for patients.